Patients
Thirty-two patients with diagnosis of dyslipidemia were included. Dyslipidemia was defined by lipid serum levels: Cholesterol >200 mg/dl and/or triglycerides >150 mg/dl. All patients were without pharmacological treatment at the time of the study. Twenty-two healthy individuals with normal lipid levels were also included (cholesterol <200 mg/dl and triglycerides <150 mg/dl). All subjects were recruited from the University Health Center of the Universidad Autónoma de San Luis Potosí. None of our included subjects showed evident infectious or autoimmune disease, previous acute myocardial infarction, hypertension, diabetes or cancer. Clinical data were collected for all patients, including sex, age, and tobacco use.
Clinical and demographic data were collected and are summarized in table 1. The Research Ethics Committee of the Faculty of Stomatology of the UASLP approved this study (CEI-FE-014-019). This work was carried out following The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.